eyenovia-logo 3

SEC Filings

SEC Filings

Filing date Form Description Filing Group View
4

Statement of changes in beneficial ownership of securities

3,4,5
4

Statement of changes in beneficial ownership of securities

3,4,5
8-K

Report of unscheduled material events or corporate event

Current Reports
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
424B4

Form of prospectus disclosing information facts events covered in both forms 424B1 424B3

Registration Statements
8-A12B

Registration of certain classes of securities 12(b) of the Securities Exchange Act

Registration Statements
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
3

Initial filing by director officer or owner of more than ten percent.

3,4,5

Contact us for more information

Contact us today to learn more about how our microdosing technology is poised to transform
the standard of care in ophthalmic therapeutic delivery.

295 Madison Ave., Suite 2400, New York, NY 10017     +1 (917) 289-1117

[email protected]